- Home
- Applications
- europe
- apheresis
Show results for
Refine by
Apheresis Product Applications In Europe
2 applications found
We adapted an autologous ex-vivo gene therapy method to load the patient’s own TEMs precursors, that are hematopoietic stem and progenitor cells (HSPCs), with an immunotherapeutic transgene sequence. By re-introducing gene-modified HSPCs into the patient, we seek to take advantage of the self-renewing and multi-differentiation capability of HSPCs to enable durable and potentially long-term effects following a single ...
ByGenenta Science based in Milano, ITALY
The global medical devices sector is undergoing a period of significant transformation largely driven by demographic shifts, evolving patient needs and technological advancements. An ageing population, combined with lifestyle related factors has resulted in a global increase in the prevalence of chronic diseases. As a result, early detection, prevention and improved management of chronic diseases has become an increasing focus for healthcare systems across the ...
ByMorgan Advanced Materials based in Windsor, NORTHERN IRELAND